Depression Care for Hospitalized Coronary Heart Disease Patients: Prospective Cohort Study (CDCare)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
University Hospital Muenster
Information provided by (Responsible Party):
Jacqueline Müller-Nordhorn, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01626027
First received: June 20, 2012
Last updated: July 29, 2015
Last verified: July 2015

June 20, 2012
July 29, 2015
June 2012
July 2015   (final data collection date for primary outcome measure)
Percentage of participants in depression care during the 12 months after hospitalization [ Time Frame: Baseline and within one year after hospitalization ] [ Designated as safety issue: No ]
Assessed via questionnaire (self-reported psychotherapy for depression and / or antidepressant medication and / or other treatment) at baseline, 1month, 6 month and 12 months Additionally, antidepressant medication prescription will be assessed at baseline via chart review (antidepressant medication at admission and discharge)
Not Provided
Complete list of historical versions of study NCT01626027 on ClinicalTrials.gov Archive Site
  • Percentage of participants reporting current utilization of mental health care and satisfaction with mental health care [ Time Frame: Baseline and within one year after hospitalization ] [ Designated as safety issue: No ]

    Current mental health care utilization is assessed via questionnaire with a single item ("yes or no").

    Satisfaction with current mental health care is assessed via questionnaire with a single continuous rating item (ranging from "very satisfied to not at all satisfied") at baseline and all follow-up assessments (1mo, 6mo and 12months)

  • Patient preferences for different providers and settings of mental health care services, as indicated by the percentage of patients who indicate actual receipt of or potential willingness to receive mental health care by specific providers and settings [ Time Frame: Baseline and within one year after hospitalization ] [ Designated as safety issue: No ]
    Assessed via questionnaire with at baseline and all follow-up assessments (1mo, 6mo and 12months). A list of mental health care providers (e.g., general practitioner, psychotherapist, psychiatrist, ...) is provided and for each, patients are asked to indicated whether they currently receive mental health care from any provider and if not, if they would be willing to reciev mentral health care by that provider, should they ever be in need (answer options "yes, maybe, no").
  • Percentage of patients in need for depression health care according to existing recommendations [ Time Frame: Baseline and within one year after hospitalization ] [ Designated as safety issue: No ]

    Baseline: Percentage of patients with a current Major Depressive Episode as assessed via the Composite International Diagnostic Interview (CIDI).

    6 months assessment: percentage of patients with a current Major Depressive Episode as assessed via the Composite International Diagnostic Interview (CIDI) - this will only be conducted in a subsample of 300 consecutive participants.

    Follow-up assessments: percentage of patients with persistently elevated depressive symptoms as indicated by a score of >=10 on the Patient Health Questionnaire (PHQ-9) at baseline and the follow-up assessments.

Not Provided
Not Provided
Not Provided
 
Depression Care for Hospitalized Coronary Heart Disease Patients: Prospective Cohort Study
Depression Care for Hospitalized Coronary Heart Disease Patients: Bridging the Gap Between Guidelines and Reality

The aims of this prospective, observational study are to assess the current use of depression care in Coronary Heart Disease (CHD) patients, and to provide estimates for the resources needed to implement guideline-oriented depression health care acceptable to CHD patients with comorbid depression.

In patients with established CHD, unipolar depression is up to three times more prevalent than in the general population and increases the risk for coronary events and mortality, higher health care consumption and decreased quality of life. Most hospitals in Germany have a unique infrastructure of psychiatric, psychosomatic and psychosocial services for CHD patients (psychiatric/psychosomatic consultation liaison services and a wide network of inpatient or outpatient cardiac rehabilitation centers). However, as of today, little is known about the current use and acceptability of depression health care from the perspective of CHD patients.

This project has two main aims:

  1. to assess the current use of depression care in CHD patients who are hospitalized or receive ambulatory care at a cardiology clinic
  2. to provide estimates for the resources needed to implement guideline-oriented depression health care acceptable to CHD patients with comorbid depression.

Specifically, the investigators will assess

  • rates of and satisfaction with depression health care use in hospitalized CHD patients within one year after hospitalization
  • perceived need for depression care and patient preferences for different types, settings and providers of these services
  • correlates of depression health care use and patient preferences
  • the amount of patients in need for depression health care according to existing recommendations

The secondary objective is to assess direct and indirect costs associated with depressive symptoms and depression care use across 1 year (as indicated by quality of life, event-free survival, productivity, and health care costs).

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Patients with confirmed Coronary Heart Disease (CHD) hospitalized in the coronary care units of 2 University hospitals in Germany. Additionally, starting August 2012, patients with confirmed CHD who receive ambulatory care at one of the cardiology clinics will also be enrolled.

  • Coronary Heart Disease
  • Depression
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
1500
August 2015
July 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • chronic CHD (confirmed by a clinician)

Exclusion Criteria:

  • chart-documented dementia disorder
  • cognitive impairment
  • life expectancy < 1 year
  • unavailability for follow-up
  • insufficient proficiency in German or Turkish language
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT01626027
01GY1154
No
Jacqueline Müller-Nordhorn, Charite University, Berlin, Germany
Charite University, Berlin, Germany
University Hospital Muenster
Principal Investigator: Jacqueline Müller-Nordhorn, MD, DPH Charité Universitätsmedizin
Charite University, Berlin, Germany
July 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP